Frontiers in Genetics | Cancer Genetics and Oncogenomics

Confident young woman gesturing while teaching students in class

Submit your research

Start your submission and get more impact for your research by publishing with us.

Active senior woman concentrating while working on laptop

Author guidelines

Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.

Front view portrait of African American man wearing lab coat and raising hand asking question while sitting in audience and listening to lecture on medicine

Editor guidelines

Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.

Smiling colleagues doing research over laptop computer on desk in office

Peer review

Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.

Interior of a library with desks and bookshelves

Publishing fees

Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.

Editors

See all

michael baudis

University of Zurich

Zürich, Switzerland

Specialty Chief Editor

Cancer Genetics and Oncogenomics
anton a. buzdin

European Organisation for Research and Treatment of Cancer

Brussels, Belgium

Specialty Chief Editor

Cancer Genetics and Oncogenomics
jorge melendez-zajgla

National Institute of Genomic Medicine (INMEGEN)

Mexico City, Mexico

Assistant Specialty Chief Editor

Cancer Genetics and Oncogenomics
mehdi pirooznia

Johnson & Johnson

Washington, D.C., United States

Assistant Specialty Chief Editor

Cancer Genetics and Oncogenomics

Cancer Genetics and Oncogenomics

Submit your research

Author guidelines

Editor guidelines

Peer review

Publishing fees

Editors

michael baudis

anton a. buzdin

jorge melendez-zajgla

mehdi pirooznia

Articles

Prognosis of cholangiocarcinoma patients based on multiple patterns of programmed cell death, integrated analysis of the immune microenvironment and drug sensitivity

Polymorphisms in circadian rhythm genes and differentiated thyroid cancer risk

IFI35 and IFIT3 are potentially important biomarkers for early diagnosis and treatment of esophageal squamous cell carcinoma: based on WGCNA and machine learning analysis

Expression and clinical significance of FANCI gene in pan-cancer: a comprehensive analysis based on multi-omics data

Research Topics

Unraveling Germline Mutations: Advances in Genetic Profiling for Cancer Risk

Genes Involved in the Metabolism of Nutrients and Drugs, and Their Roles in Cancer, Immune Disorder and Aging

Advancements in head and neck tumor treatment strategy driven by the perspective of precision oncology

Deciphering molecular mechanisms behind tumor heterogeneity features by using nucleic acid-based technologies